Novo Nordisk signed a licensing deal worth up to $1.3 billion with Sweden's Nanexa for drug-coating technology to create longer-lasting obesity and diabetes shots

BusinessSep 25 at 1:43 AM – Sep 25 at 9:46 AM4 outlets

Bloomberg

Novo Signs Delivery Deal With Nanexa Worth Up to $1.3 Billion Opens in new window seen Sep 25 at 2:08 AM

Novo Signs Delivery Deal With Nanexa Worth Up to $1.3 Billion Sep 25 at 1:43 AM

CNBC

Pharma stock soars 150% on injectables deal with Wegovy maker Novo Sep 25 at 5:58 AM

Quartz

Novo Nordisk signed a $1.3 billion deal for technology to make longer-lasting obesity shots Sep 25 at 9:46 AM

MarketWatch

After capital-markets day flop, Novo strikes licensing deal that sends a Swedish company’s stock soaring Sep 25 at 5:11 AM